Page last updated: 2024-09-05

deflazacort and Giant Cell Arteritis

deflazacort has been researched along with Giant Cell Arteritis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Devogelaer, JP; Gennari, C1
Blanco, R; González-Gay, MA; Monte, R; Santiago, J1
Belmatoug, N; Cacoub, P; Chemlal, K; Cohen, P; De Gennes, C; Khalifa, P; Piette, JC; Verdoncq, B; Wechsler, B; Ziza, JM1

Trials

1 trial(s) available for deflazacort and Giant Cell Arteritis

ArticleYear
Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
    The Journal of rheumatology, 2001, Volume: 28, Issue:11

    Topics: Absorptiometry, Photon; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Bone Density; Bone Diseases, Metabolic; Calcium; Double-Blind Method; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Middle Aged; Multicenter Studies as Topic; Prednisone; Pregnenediones; Prospective Studies; Spinal Fractures; Treatment Outcome; Vitamin D

2001

Other Studies

2 other study(ies) available for deflazacort and Giant Cell Arteritis

ArticleYear
Deflazacort in giant cell arteritis.
    The Journal of rheumatology, 2002, Volume: 29, Issue:10

    Topics: Anti-Inflammatory Agents; Bone Density; Bone Diseases, Metabolic; Calcifediol; Dietary Supplements; Dose-Response Relationship, Drug; Giant Cell Arteritis; Humans; Prednisone; Pregnenediones; Randomized Controlled Trials as Topic

2002
Low-dose corticosteroids and blindness in giant cell arteritis.
    British journal of rheumatology, 1996, Volume: 35, Issue:7

    Topics: Aged; Anti-Inflammatory Agents; Blindness; Dose-Response Relationship, Drug; Giant Cell Arteritis; Humans; Male; Prednisone; Pregnenediones

1996